Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from Sinco Pharmaceuticals Holdings Ltd. ( (HK:6833) ).
Sinco Pharmaceuticals Holdings Limited has announced changes in its Nomination Committee and the appointment of a new Lead Independent Non-Executive Director. Ms. Jing Huan and Mr. Bai Zhizhong have been appointed to the Nomination Committee, with Mr. Bai also taking on the role of Lead INED. These changes aim to enhance the company’s corporate governance by increasing the diversity and effectiveness of the Nomination Committee, in line with the updated Corporate Governance Code and listing rules.
The most recent analyst rating on (HK:6833) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Sinco Pharmaceuticals Holdings Ltd. stock, see the HK:6833 Stock Forecast page.
More about Sinco Pharmaceuticals Holdings Ltd.
Sinco Pharmaceuticals Holdings Limited is a company incorporated under the laws of the Cayman Islands, operating in the pharmaceutical industry. The company is listed on the Stock Exchange of Hong Kong and focuses on pharmaceutical products and services.
Average Trading Volume: 280,181
Technical Sentiment Signal: Buy
Current Market Cap: HK$496M
For detailed information about 6833 stock, go to TipRanks’ Stock Analysis page.